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Outcome of Limited Resection for Lung Cancer 
Jeong  Su  Cho,  M.D.*,  Sanghoon  Jheon,  M.D.**,***,  Sung  Joon  Park,  M.D.***, 
Sook-Whan  Sung,  M.D.**,***,  Choon  Taek  Lee,  M.D.**,***
Background:  Up to now, lobectomy, bilobectomy and pneumonectomy combined with extensive lymph node dis-
section have been regarded as the standard procedures for non-small cell lung cancer (NSCLC). In high-risk pa-
tients, however, limited resection (LR) has been attempted as a salvage procedure, and, recently, indication for LR 
has been extended to selected cases with early-stage NSCLC. Material and Methods: Among the 773 patients 
who underwent surgical procedures for NSCLC in Seoul National University Bundang Hospital from May 2003 to 
December 2008, 43 patients received LR. Medical records of these patients were retrospectively reviewed. Results: 
Mean age at operation was 66.0±12.4 years, and there were 30 males. Twenty-five patients underwent con-
servative limited resection (CLR) and 18 underwent intentional limited resection (ILR). Indications for CLR were mul-
tiple primary lung cancer in 9 (9/25, 36%) and severe concomitant diseases in 5 (5/25, 20%). Of these, 6 patients 
underwent segmentectomy and 19 received wedge resection. During the follow-up period of 28.0±17.8 months, 15 
patient developed recurrent lung cancer. ILR was selectively performed in lesions almost purely composed of 
ground glass opacity (≥95%), or in small solid lesions (≤2 cm). Of these, 11 patients underwent segmentectomy 
and 7 underwent wedge resection. During the follow-up period of 31.7±11.6 months, no patient developed 
recurrence.  Conclusion: Intermediate-term outcome of LR for early-stage lung cancer is comparable to that of 
standard operation. For the delineation of the indications and appropriate surgical techniques for LR, prospective 
randomized multi-institutional study may be expedient. 
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INTRODUCTION
Ever  since  the  clinical  reports  in  1950s  indicated  that  lo-
bectomy  is  superior  to  pnemonectomy  in  terms  of  survival 
and  postoperative  complications  [1-3],  pulmonary  lobes  have 
been  regarded  as  the  basic  units  of  surgical  excision  in 
non-small  cell  lung  cancer  (NSCLC).  Thus,  lobectomy,  bi-lo-
bectomy  and  pneumonectomy  in  combination  with  extensive 
lymph  node  dissection  have  long  been  the  standard  proce-
dures  for  NSCLC.  In  patients  with  poor  lung  function  or 
compromised  general  condition,  however,  limited  resection 
(LR) of the lung has also been performed as a salvage proce-
dure  (i.e.  conservative  LR  or  CLR),  and,  from  this  experi-
ence,  indication  for  LR  has  been  extended  to  selected  cases Jeong Su Cho, et al
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Table 1. Number of patients with lung cancer according to the 
types of resection 
Type  of  resection Number  of  patient  (n=773)
Pneumonectomy   49
Bilobectomy   39
Lobectomy 614
Sublobar  resection   68
  F o r  p r i m a r y  l u n g  c a n c e r    4 3
  F o r  r e c u r r e d  l u n g  c a n c e r  2 5
of early-stage NSCLC as a minimally invasive procedure (i.e. 
intentional  LR  or  ILR).  Given  the  preoperative  condition  of 
the patients, the outcome of CLR is presumed to be poor. To 
the contrary, the outcome of LR for early-stage NSCLC, par-
ticularly  in  cases  with  low  grade  malignancy,  would  well  be 
good,  considering  less  aggressive  nature  of  the  cancer,  less 
surgical  trauma  and  minimal  excision  of  normal  lung  tissue. 
The  exact  indication  and  appropriate  surgical  technique  of 
LR,  however,  have  remained  unclear  and  arbitrary,  because 
they  are  mainly  based  on  individual  surgeon’s  preference 
rather than a scientific algorithm. Thus, by analyzing the pre-
operative  patient  characteristics  and  postoperative  outcome  of 
LR  in  our  series,  we  sought  to  delineate  the  subset  of  pa-
tients  with  NSCLC  who  would  best  benefit  from  this  new 
therapeutic  strategy,  which  may  help  to  postulate  a  guideline 
of  LR  for  this  disease  entity.
MATERIAL AND METHODS
Between  May  2003  and  December  2008,  773  patients  un-
derwent  lung  resection  for  NSCLC  in  our  institute,  and  the 
extent  of  the  excised  lung  tissue  was  smaller  than  a  lobe  in 
68  patients,  including  43  patients  with  primary  lung  cancer 
who  constituted  study  population  in  this  research.  There  had 
been  no  well-established  guideline  or  principle  regarding  the 
indication  for  limited  resection  (LR)  during  this  time  frame, 
and  the  employment  of  LR  strategy  was  at  the  discretion  of 
individual  surgeon’s  decision.  Consent  to  LR  was  obtained 
preoperatively  in  all  patients  after  fully  detailed  information 
regarding  LR  was  provided.  For  the  preoperative  diagnostic 
work-up,  all  patients  underwent  chest  computerized  tomog-
raphy  (CT)  scanning,  and  other  diagnostic  studies,  such  as 
positron  emission  tomography  (PET),  bronchoscopy,  percuta-
neous  needle  aspiration,  and  mediastinoscopy,  were  se-
lectively  conducted,  if  indicated.  For  the  prediction  of  post-
operative  pulmonary  function  and  determination  of  oper-
ability,  pulmonary  function  test  (PFT)  was  performed  in  all 
patients,  and  other  studies,  such  as  treadmill  test,  echo-
cardiography and myocardial SPECT (Single-Photon Emission 
Computed  Tomography),  were  selectively  done.  Surgery  was 
conducted  through  open  thoracotomy  or  thoracoscopic  ap-
proach, and the latter was preferred to the former, if possible. 
Postoperative  follow-up  in  the  out-patient  department  (OPD) 
was  monthly for  postoperative  3  months,  every  3  months be-
tween  postoperative  3  months  and  3  years,  every  4  months 
between  postoperative  3  years  and  5  years,  and  every  6 
months  from  then  on.  There  was  no  follow-up  loss.  Studies 
for  postoperative  assessment  in  the  OPD,  such  as  simple 
chest X-ray, chest CT, PET scan, bronchoscopy, PFT, and tu-
m o r  m a r k e r  a s s a y ,  w e r e  p e r f o r m e d  i n  a  t i m e l y  m a n n e r ,  a n d  
more  frequently  if  cancer  recurrence  was  suspected.   
RESULTS
The  extent  of  lung  resection  in  the  773  patients  with 
NSCLC  is  summarized  in  Table  1.  Among  the  68  patients 
who  underwent  LR,  postoperative  pathological  diagnosis  was 
proven  to  be  primary  lung  cancer  in  43,  who  constituted 
study  population.  Their  age  were  66.0±1 2 . 4  y e a r s ,  a n d  3 0  
were  males.  LR  was  done  as  a  salvage  procedure  in  25 
(conservative  LR  or  CLR  group)  and  was  done  as  a  mini-
mally  invasive  procedure  for  early-stage  lung  cancer  in  18 
(intentional  LR  or  ILR  group). 
The rationales for CLR are summarized in Table 2. Among 
the  25  patients  with  CLR,  10  had  surgical  risk  score,  pro-
posed  by  American  society  of  anesthesiologists  (ASA  score), 
o f  3  o r  4 .  I n  t h e  4  p a t i e n t s  w h o  h a d  C L R  f o r  p o o r  p u l m o -
nary  function,  their  forced  expiratory  volume  in  one  second 
was  1.11±0 . 2 2  L  ( 5 3 ±19%  of  predicted  value).  Preoperative 
clinical staging of the NSCLC was stage I in 20, II to IIIa in 
3,  IIIb  in  1  and  IV  in  1.  Among  the  20  patients  with  pre-
operative  stage  I,  7  remained  to be  stage  I  postoperatively,  1 
changed to stage II due to positive regional lymph node, and, 
in  the  remaining  12,  precise  cancer  staging  remained  un-Limited Resection for Lung Cancer
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Table 2. Reasons of limited resection
           R e a s o n s N u m b e r  o f  p a t i e n t s
Conservative  limited  resection  (n=25)
Double  primary  lung  cancer   9  (36%)
Poor  lung  function   4  (16%)
Extrapulmonary  primary  cancer   4  (16%)
Advanced-stage  lung  cancer   3  (12%)
Severe  lung  disease   3  (12%)
Severe  accompanying  disease 2  (8%)
Intentional    limited  resection  (n=18)
Mixed  GGO  or  solid  lesion  and   9  (50%)
  small-sized  lesion*
Pure  GGO  or  nearly  pure  GGO  lesion
†   8  (44%)
Others
‡ 1  (5%)
GGO=Ground  glass  opacity;  *=Small  size:  ≤2  cm; 
†=Nearly 
p u r e  G G O  l e s i o n :  G G O ＞95%  of  the  lesion; 
‡=Tumor  size: 
2.3  cm  and  mixed  GGO  lesion.
certain  because  extensive  lymph  node  dissection  was  dis-
pensed  with  due  to  the  palliative  nature  of  the  procedure. 
Two  patients  with  stage  IIIb  showed  intra-pleural  seeding  of 
the cancer (T4N0M0), and received CRL of the primary can-
cer  with  intra-pleural  hyperthermic  perfusion  therapy.  As  to 
the  surgical  technique  of  LR,  6  received  segmentectomy  and 
19  had  wedge  resection,  and  resection  of  the  primary  tumor 
was  deemed  complete  (R0  resection)  in  22  and  incomplete 
(R1,  R2  resection)  in  3.  Surgical  approach  was  thoracoscopic 
in  11  (segmentectomy:  1,  wedge  resection:  10).  Lymph  node 
dissection was dispensed with in 14, selectively sampled in 8, 
and  extensively  done  in  3.  Pathological  types  were  adeno-
carcinoma  in  11,  squamous  cell  carcinoma  in  11,  bronchio-
loalveolar  carcinoma  in  2,  and  larger  cell  tumor  in  1.  Posto-
perative  hospital  stay  was  7.58±4.4  days.  Postoperative  com-
plications  developed  in  7,  and  most  of  them  were  not  sig-
nificant except for one case of surgical bleeding which neces-
sitated  reoperation.  There  was  no  surgical  mortality.  Late 
deaths  occurred  in  12,  and  10  were  related  to  cancer  recur-
rence.  Follow-up  was  complete  with  a  mean  duration  of 
28.0±17.8  months,  and,  during  the  follow-up,  cancer  re-
currence  occurred  in  15.  Mean  expected  duration  of  can-
cer-free  survival  was  18.5±16.8  months.  Recurrence  devel-
oped in the same side as the primary lung cancer in 6 (in the 
same  lobe  in  4,  in  the  resection  m a r g i n  i n  2 ) ,  i n  t h e  l y m p h  
node in 1, in the chest wall in 2, in the contra-lateral lung in 
3,  and  in  the  distant  location  in  3.  The  primary  cancer  stage 
of the 15 patients who developed recurrence was uncertain in 
8,  stage  I  in  3,  II  and  IIIa  in  3,  IIIb  in  1  and  IV  in  1.  Ten 
patients with recurrent lung cancer have died to date, and the 
remaining  5  patients  have  received  chemotherapy  or  radio-
therapy  with  partial  (n=3)  or  no  remission  (n=2). 
ILR strategy was selected based on the tumor size, location 
and  the  degree  of  the  association  of  ground  glass  opacity 
(GGO), which signifies low-grade malignancy. Among the 18 
patients  with  ILR,  11  had  segmentectomy  and  7  had  wedge 
resection.  The  indications  for  wedge  resection  were  small 
sized  (≤2  cm)  pure  GGO  lesion  (n=4),  and  small  (≤2  cm) 
peripheral  mixed  GGO-solid  lesion  (n=3).  These  criteria  for 
wedge  resection,  however,  were  not  exclusively  applied,  for 
one  patient  who  had  1.6  cm-sized  pure  GGO  lesion  received 
segmentectomy.  The  indications  for  segmentectomy  were 
small lesion without GGO lesion, or mixed GGO-solid tumor 
with solid lesion  dominance. PET scan was performed in  pa-
tients with solid tumor dominance  (n=9),  and  maximal stand-
ardized  uptake  value  was  2.13±2.04.  Among  these  nine  pa-
tients,  there  were  cases  with  non-visualization  of  the  tumor 
on  PET  scan.  With  respect  to  surgical  approach,  both  thor-
acoscopic  approach  (n=9)  and  open  thoracotomy  approach 
(n=9)  were  used  equally.  Postoperative  hostpital  stay  was 
6.24±3.49  days,  and  postoperative  follow-up  duration  was 
31.7±11.6  months.  On  postoperative  pathologic  examination, 
five patients showed findings of bronchioloalveolar carcinoma 
(BAC),  and  4  received  wedge  resection.  When  Noguchi  clas-
sification system [4] for adenocarcinoma was applied for five 
patients  with  BAC,  the  number  of  patients  with  type  A,  B 
and  C  was  1,  2,  and  2,  respectively.  One  patient  with  BAC 
who  had  segmentectomy  was  proven  to  have  type  C  lesion. 
In patients with ILR, there was no difference in postoperative 
course  between  wedge  resection  group  and  segmentectomy 
group,  except  for  the  hospital  stay,  which  was  longer  in  the 
latter (Table 3). There was no recurrence of lung cancer dur-
ing the follow-up period. One patient died of colon cancer 41 
months  after  the  lung  cancer  surgery.
Clinical characteristics of patients with LR according to the 
rationale  for  LR  (i.e.  CLR  versus  ILR)  are  summarized  in 
Table  4.  There  were  significant  differences  in  FEV1,  tumor 
size,  ASA  risk  score  and  the  surgical  procedure  (wedge  re-Jeong Su Cho, et al
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Table 3. Comparison of tumor characteristics and clinicopathological parameters of the patients with stage Ia NSCLC according to the sur-
gical procedures of intentional limited resection
Variables Wedge  resection  Segmentectomy p-value
Total  number  of  patients
Age  (Mean±SD,  years)
Gender,  male : female
ASA  score
1∼2
3∼4
FEV1  (Mean±SD,  liter)
Tumor  size  (Mean±SD,  cm)
Tumor  histology
Adenocarcinoma
BAC
Squamous  cell  carcinoma
Others
Type  of  approach
Thoracotomy
VATS
Number  of  dissected  lymph  node  (Mean±SD)
Complications
Postoperative  hospital  stay  (Mean±SD,  days)
Follow  up  duration  (Mean±SD,  months)
7
64.52±11.48
4:3
6
1
2.43±0.43
1.20±0.34
3
4
0
0
2
5
2.5±0.7
0
3.71±0.95
29.7±12.4
11
61.05±11.79
6:5
10
 1
2.38±0.56
1.61±0.77
 6
 2
 1
 2
 7
 4
9.0±5.7
 2
8.00±3.56
31.4±12.4
0.548
1.000
0.896
0.833
0.205
0.486
0.335
0.151
0.497
0.004
0.781
NSCLC=Non-small  cell  lung  cancer;  SD=Standard  deviation;  ASA=American  society  of  anesthesiologists;  FEV1=Forced  expiratory 
volume  in  1  second;  BAC=Bronchioloalveolar  carcinoma;  VATS=Video-assisted  thoracic  surgery.
section  versus  segmentectomy)  between  the  two  groups. 
DISCUSSION
Application  of  LR  strategy  for  NSCLC  is  still  contro-
versial.  While  Ginsberg  and  Rubinstein  [5]  claimed  that  the 
outcome of LR for early-stage lung cancer is worse than that 
of  more  extensive  resection,  others  asserted  that  long-term 
outcome  of  LR  would  be  better  than  that  of  lobectomy  be-
cause  larger  amount  of  normal  lung  tissue  is  preserved  while 
the  risk  of  cancer  recurrence  is  comparable  to  lobectomy 
[6-11]. This striking discrepancy in outcome interpretation be-
tween  various  clinical  researches  pertaining  to  this  issue  may 
result  from  the  differences  in  study  population,  non-stand-
ardized  surgical  technique,  and  lack  of  consensus-based  treat-
ment  algorithm.
Conservative  LR  (CLR)  has  been p e r f o r m e d  f o r  a  v a r i o u s  
proportion  of  patients  with  hardly-operable/hardly-resectable 
NSCLC,  depending  on  the  indication  for  LR  or  capability  of 
each program in postoperative care. The rationale for conven-
tional LR centers around improving early survival and quality 
of life, and preoperative risk analysis should be cautiously fo-
cused on precise assessment of risk-benefit relationship on an 
individual patient basis. Because patients with stage I NSCLC 
who  are  indicated  for  non-surgical  treatment  due  to  multiple 
risk  factors  are  rare,  there  have  been  only  a  few  reports  on 
the long-term outcome of CRL in comparison to radiotherapy 
or  chemotherapy  [12,13]  for  this  subset.  In  our  study,  the 
overall  surgical  outcome  after  CRL  was  less  than  optimal 
with  high  recurrence  rate.  This  could  partly  be  attributed  to 
advanced disease in 5 patients whose clinical stage was high-
er than II, and pathologic staging of the patients with clinical 
stage  I  could  have  been  changed  to  a  higher  grade  if  they 
had had extensive lymph node dissection. Furthermore, all pa-
tients  except  for  two  had  solid  tumor  without  ground  glass 
opacity, and their maximal standardized uptake value (MSUV) 
on  PET  scan  was  higher  than  3.0,  which  was  the  average 
MSUV  of  whole  population  with  stage  I  NSCLC  during  the 
same  time  frame.  These  findings  suggest  that  patients  with 
preoperatively ‘presumed’ stage I would have had a high risk Limited Resection for Lung Cancer
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Table 4. Comparison of tumor characteristics and clinicopathological parameters of patients with NSCLC according to the rationales for 
limited resection
Variables Conservative  Intentional p-value
Total  number  of  patients
Age  (Mean±SD,  years)
Sex  (male : female)
ASA  score
1∼2
3∼4
FEV1  (Mean±SD,  liter)
Tumor  size  (Mean±SD,  cm)
Tumor  pathology
Adenocarcinoma
BAC
Squamous  cell  carcinoma
Others
Types  of  resection
Segmentectomy
Wedge  resection
Number  of  lymph  node  (Mean±SD)
Postoperative  hospital  stay  (Mean±SD,  days)
Follow  up  duration  (Mean±SD,  months)
Recurrence 
Cancer  related  death
25
68.63±12.58
20 : 5
15
10
1.98±0.72
2.10±1.45
11
 2
11
 1
 6
19
9.36±8.08
7.58±4.40
28.0±17.8
15  (60.0%)
10  (40.0%)
18
62.40±11.46
10 : 8
16
 2
2.40±0.49
1.45±0.65
 9
 6
 1
 2
11
 7
7.92±5.73
6.24±3.49
31.7±11.6
 0
 0
0.104
0.105
0.046
0.042
0.049
0.339
0.026
0.623
0.301
0.519
NSCLC=Non-small  cell  lung  cancer;  SD=Standard  deviation;  ASA=American  society  of  anesthesiologists;  FEV1=Forced  expiratory 
volume  in  1  second;  BAC=Bronchioloalveolar  carcinoma.
of recurrence even  after conventional resection,  and extensive 
lymph  node  dissection  might  have  lowered  the  recurrence 
rate, at least to some extent. Considering the 6 cases with lo-
cal  recurrence  at  the  resection  margin  or  in  the  same  lobe, 
some  may  argue  that  they  would  have  benefitted  from  con-
ventional resection in terms of recurrence rate. However, giv-
en  that  4  of  the  6  patients  were  older  than  70  years,  2  had 
severe  associated  lung  disease, 2  h a d  m u l t i p l e  l u n g  c a n c e r ,  
and  one  had  ASA  grade  of  3,  it  is  prudent  to  say  that  these 
patients  would  have  poorly  tolerated  lung  resection  more  ex-
tensive  than  limited  resection. 
W i t h  r e s p e c t  t o  i n t e n t i o n a l  L R  ( I L R ) ,  i n d i c a t i o n s  f o r  p e r -
forming  ILR  are  less  complicated  than  CLR.  As  to  the  size 
of the primary tumor, Tsubota et al proposed rationale for in-
tentionally  performed  segmentectomy  for  NSCLC  with  small 
lesion  (≤2  cm),  and  they  have  accumulated  data  to  sub-
stantiate their novel strategy [6-8].  New TNM  staging  system 
categorizes small tumor (≤2 cm) as T1a, and this sub-classi-
fication  is  expected  to  boost  the  application  of  ILR  for  early 
stage  NSCLC  [14].  This  new  strategy,  however,  may  render 
extensive  lymph  node  dissection  even  more  important,  and 
planned  ILR  should  be  converted  to  conventional  resection 
once  lymph  node  metastasis  becomes  evident  by  frozen 
biopsy.  As  to  the  pathologic  type  of  NSCLC,  Noguchi  et  al 
proposed  a  histologic  classification  of  adenocarcinoma  [4], 
which  has  been  proven  to  correlate  well  with  the  degree  of 
ground  glass  opacity  on  chest  CT  [15,16].  Based  on  recent 
studies  from  Japan  [17,18],  patients  with  pure  GGO  on  chest 
CT,  which  is  equivalent  to  Noguchi  type  A  or  B,  are  good 
candidates  for  wedge  resection,  because  the  malignant  poten-
tial  of  this  lesion  is  even  lower  than  that  of  small  peripheral 
lung  cancer.  However,  the  application  of  ILR  for  GGO  le-
sions  is  still  controversial,  and  only  a  few  studies  have  been 
undertaken in western countries. Furthermore, there is no con-
sensus  on  the  extent  of  lung  resection  for  GGO,  and  some 
favor  wedge  resection  as  a  definitive  surgery  while  others 
perform  segmentectomy  or  lobectomy  after  pathologic  diag-
nosis  is  obtained  by  frozen  biopsy  from  the  wedge  resection Jeong Su Cho, et al
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specimen.  The  rationales  for  the  former  strategy  are  as  fol-
lows:  1)  The  differentiation  between  Noguchi  type  A  lesion 
(localized  bronchioloalveolar  carcinoma,  LBAC)  and  atypical 
adenomatous hyperplasia (AAH) is difficult by frozen biopsy, 
2)  Procurement  of  tumor  tissue  for  frozen  biopsy  may  jeop-
ardize the precise pathologic assessment later on, 3) By some 
scholars, Noguchi type A or B lesions are classified as carci-
noma  in  situ  or  stage  0  disease  [4],  and,  therefore,  it  is  sen-
sible  to  minimize  surgical  excision  for  very  early  stage  dis-
ease  in  which  intra-lobar  spread  of  the  cancer  is  less  likely.
Current  practice  for  NSCLC  in  Korea  is  characterized  by 
decreased frequency of pneumonectomy, sleeve lobectomy, or 
other types of extensive resection, which may be due, at least 
in  part,  to  the  decreased  incidence  of  once-prevailing  cen-
tral-type  squamous  cell  carcinom a .  T o  t h e  c o n t r a r y ,  t h e  i n -
creasing number  of peripheral  adenocarcinoma  or stage I dis-
ease has propelled the less  extensive surgery employing thor-
acoscopic surgery technique. This contemporary trend towards 
minimally  invasive  surgery,  however,  has  more  to  do  with 
minimizing  surgical  trauma  and  hospital  stay,  rather  than 
minimizing the  extent of  surgery  for  lung  cancer,  which  may 
violate  the  principles  for  cancer  surgery.  In  a  practical  sense, 
segmentectomy  or  wedge  resection  as  a  cancer  surgery  is  a 
technically  more  demanding  and  complicated  compared  to 
those for benign lung lesions. In this regard, standard surgical 
technique  of  ILR  needs  to  be  defined.  Furthermore,  the  con-
sensus-based  criteria  for  ILR  in  early-stage  NSLCL  have  not 
established  yet.  Given  that  the  number  of  patients  with  pe-
ripheral  tumors  and  GGO  lesions,  who  are  potential  candi-
dates for ILR, is rapidly growing in Korea, benefits from ILR 
for  this  subset  should  be  delineated  as  soon  as  possible,  by 
thorough  review  of  the  patients  who  were  indicated  for  ILR. 
Multi-institutional  study  may  be  expedient  to  this  end. 
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